Revance Therapeutics Inc announces positive topline data from its JUNIPER Phase 2, randomized, double-blind, placebo-controlled, multi-center clinical trial of its investigational drug candidate DaxibotulinumtoxinA for Injection for the treatment of adults with moderate to severe upper limb spasticity.
According to a new study published in Frontiers in Political Science, voters do not apply negative stereotypes when evaluating candidates with a disability. Rather, they tend to perceive candidates with a disability as capable, honest, and caring.
The results are clear but the debate about the drug’s effectiveness in treating COVID-19 will almost certainly continue. Here is what the scientific method reveals about the drug’s performance.
Dewpoint Therapeutics announces a new research collaboration with Pfizer for the development of potential therapeutics for the treatment of myotonic dystrophy type 1, DM1, a rare genetic disorder and one of two types of myotonic dystrophy.
Read More
The damaging effects of obesity are not due to body weight but rather come from something much smaller: biochemical signals released by fat cells, a study from Shriners Hospitals for Children – St. Louis published in Proceedings of the National Academy of Sciences suggests.
Read More
Persons with spinal cord injury and older healthy individuals have similar brain activation during processing speed tasks, according to this Kessler Foundation study, which researchers suggest supports the theory of accelerated cognitive aging following spinal cord injury.
Read More
Short-term “prehabilitation” strength exercises, undertaken pre-surgery, are insufficient to prevent muscle loss, researchers in the University of Birmingham’s School of Sport, Exercise and Rehabilitation Sciences suggest.
Read More
The antiepileptic drug ezogabine reduced pathologic excitability of cortical and spinal motor neuron cells that are early signs of clinical dysfunction in people with amyotrophic lateral sclerosis (ALS)
Read More
Findings from a gene activity study published online recently in PNAS could lead to new treatments for Duchenne muscular dystrophy (DMD) and offer insights into factors that affect muscle development.
Read More
Almost 2 years into a research study conducted by Johns Hopkins APL and Johns Hopkins Medicine, a quadriplegic patient can now control two robotic arms with his brain — and can even feed himself, researchers share.
Read More
Target ALS announces the second round of recipients in 2020 receiving grants to fund studies focused on discovering and developing ALS biomarkers, in a media release.
Read More
Sensory stimulation enhances users’ perception of their phantom hand and leads to more reliable and repeatable muscle movement signals, which are used to control a prosthetic arm, Johns Hopkins Applied Physics Laboratory (APL) researchers suggest, in a study published recently in the Journal of Neural Engineering.
Read MoreLate Thursday afternoon, Dec. 10, an advisory panel from the U.S. Food and Drug Administration (FDA) gave its endorsement to BNT162b2, the vaccine developed by Pfizer Inc and BioNTech SE to treat COVID-19.
Read More
Large doses of vitamin D supplements were no better at preventing falls in people age 70 and older than low doses. They could possibly even raise the fall risk, researchers suggest in the Annals of Internal Medicine.
Read More
The wallet-sized cards that will ship with Operation Warp Speed’s vaccine kits feature a follow-up dose reminder.
Read More
Researchers from Skoltech and the University of Texas at Austin have presented a proof-of-concept for a wearable sensor designed to track healing in sores, ulcers, and other kinds of chronic skin wounds, even without the need to remove the bandages.
Read More
Individualized treatment plans and instructions would be beneficial to both patients and their caregivers upon returning home after a stay in the hospital and a skilled nursing facility, according to research from Regenstrief Institute and Indiana University published in the Journal of General Internal Medicine.
Read More
Researchers from Imperial College London, in collaboration with the Santa Lucia Foundation and Casilino Hospital in Rome, have developed a non-invasive cuff that slips onto freely kicking babies’ legs to monitor neuronal activity without the need for surgery.
Read More